✦ LIBER ✦

Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer

✍ Scribed by Nozomu Fuse; Toshihiko Doi; Atsushi Ohtsu; Tomonori Yano; Yasuo Hamamoto; Keiko Minashi; Makoto Tahara; Manabu Muto; Masahiro Asaka; Shigeaki Yoshida

Publisher: Springer
Year: 2008
Tongue: English
Weight: 252 KB
Volume: 13
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-007-0737-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of gefitinib, irinotecan,

Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

A comprehensive review of 5-fluorouracil

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

✍ David Machover 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Background: Colorectal carcinoma is the third leading cause of cancer-related death. the primary treatment for patients with metastatic colorectal carcinoma is systemic chemotherapy with 5-fluorouracil (5-fu) and leucovorin (lv), a biomodulator of 5-fu that has been shown to enhance its activity

A multicenter phase II study of irinotec

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB

Safety of bevacizumab treatment in combi

Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients

✍ Akihiro Tamiya; Kentaro Yamazaki; Narikazu Boku; Nozomu Machida; Takashi Kojima; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 317 KB

Comparing safety and efficacy of first-l

Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer : Findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study

✍ Nadine A. Jackson; José Barrueco; Raoudha Soufi-Mahjoubi; John Marshall; Edith M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

Protracted continuous infusion of 5-fluo

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

✍ Alfredo Falcone; Giacomo Allegrini; Monica Lencioni; Elisabetta Pfanner; Isa Bru 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB